Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

2.88
-0.1800-5.88%
Pre-market: 2.910.0300+1.04%09:24 EDT
Volume:337.88K
Turnover:1.00M
Market Cap:118.32M
PE:-11.25
High:3.10
Open:3.05
Low:2.87
Close:3.06
Loading ...

U.S. RESEARCH ROUNDUP- GE Vernova, NVR, ServiceNow

Reuters
·
24 Jul

Anebulo Pharmaceuticals Inc : Maxim Group Cuts to Hold From Buy

THOMSON REUTERS
·
24 Jul

Anebulo Pharmaceuticals Cut to Hold From Buy by Maxim Group

Dow Jones
·
24 Jul

Anebulo Pharmaceuticals downgraded to Hold from Buy at Maxim

TIPRANKS
·
24 Jul

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views

Benzinga
·
24 Jul

Anebulo Pharmaceuticals Inc : Benchmark Cuts to Hold Rating

THOMSON REUTERS
·
23 Jul

Anebulo Plans Reverse Stock Split to Terminate Registration of Its Stock; Shares Up

MT Newswires Live
·
23 Jul

BRIEF-Anebulo Pharmaceuticals Approves Plan To Terminate Registration Of Common Stock

Reuters
·
23 Jul

Anebulo Pharmaceuticals Inc - Stockholders to Receive $3.50 per Pre-Split Share

THOMSON REUTERS
·
23 Jul

Anebulo Pharmaceuticals Inc - Approves Reverse Stock Split Ratio Between 1-for-2,500 and 1-for-7,500

THOMSON REUTERS
·
23 Jul

Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock

THOMSON REUTERS
·
23 Jul

Anebulo Pharmaceuticals Inc. Announces Date for Special Stockholder Meeting

Reuters
·
23 Jul

Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Waters (WAT) and Anebulo Pharmaceuticals (ANEB)

TIPRANKS
·
22 May

Anebulo Pharmaceuticals Is Maintained at Buy by Maxim Group

Dow Jones
·
16 May

Anebulo Pharmaceuticals Q3 EPS $(0.04) Beats $(0.05) Estimate

Benzinga
·
14 May

Anebulo Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Anebulo Pharmaceuticals, Inc. Q3 Basic EPS USD -0.04

Reuters
·
14 May

Anebulo Pharmaceuticals Reports Q3 Fiscal 2025 Results: Net Loss Steady at $1.7 Million, EPS Improves to $(0.04)

Reuters
·
14 May

Press Release: Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates

Dow Jones
·
14 May

Anebulo Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
09 May